IL6受体抑制剂:通过药物点门德尔随机化探索跨多种疾病的治疗潜力
Chong Fu1, Longquan Wang2, Wenjiao Cai3
1Department of Gastroenterology, Anqing Municipal Hospital, Anqing, Anhui, China.
Frontiers in immunology
|September 4, 2024
概括
介素-6受体抑制剂在治疗异常性肺纤维化,帕金森病和2型糖尿病方面表现有前途. 然而,它们可能会增加喘和喘性肺炎的风险.
科学领域:
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 高水平的IL-6与各种疾病有关,包括癌症,自身免疫性疾病和感染.
- 目前,干白素-6受体抑制剂 (IL-6Ri) 正在用于类风湿性关节炎和COVID-19.
- 潜在的更广泛的治疗应用IL-6Ri的证据调查.
研究的目的:
- 研究基因抑制IL-6受体对一系列疾病的因果关系.
- 评估IL-6受体抑制作为特定疾病治疗策略的潜力.
主要方法:
- 使用药物标孟德尔随机化 (MR) 分析.
- 与C反应蛋白相关的IL6R基因附近的单核酸多态 (SNPs) 被用作仪器变量.
- 使用了反变量加权 (IVW) 和贝叶斯门德尔随机化 (BWMR) 方法,以及灵敏度和局部化分析.
主要成果:
- IL-6抑制剂显著降低了异常性肺纤维化 (OR=0.278),帕金森病 (OR=0.354) 和2型糖尿病 (OR=0.759) 的风险.
- 相反,IL-6抑制剂增加了喘 (OR=1.327) 和喘性肺炎 (OR=1.823) 的风险.
- 来自IVW和BWMR方法的结果是一致的;sIL-6R也显示出显著的影响.
结论:
- IL-6受体抑制剂显示出潜在的治疗方法,用于治疗异常性肺纤维化,帕金森病和2型糖尿病.
- 这些发现表明IL-6信号在疾病发病过程中起着复杂的作用,观察到具有保护性和有害性的作用.
- 需要进一步的研究来阐明这些关联背后的机制,并优化治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963


